Reportlinker Adds Gastrointestinal Pharmaceuticals: Technologies a...(($ MILLIONS/%) 89 FIGURE 16 GLOBAL PR...),Health

FIGURE 16 GLOBAL PRESCRIPTION BOWEL INFLAMMATORY AGENT REVENUES BY MANUFACTURER, 2009 ($ MILLIONS) 89

OTHER GASTROINTESTINAL PRODUCTS 89

ANTISPASMODICS 90

TABLE 26 MARKETED ANTISPASMODIC PRODUCTS 90

DIGESTANTS 90

GASTRIC ACIDIFIERS 91

PANCREATIC ENZYMES 91

TABLE 27 MARKETED DIGESTANT PRODUCTS 92

EVACUANTS 92

TABLE 28 MARKETED EVACUANTS PRODUCTS 92

MUCOSAL PROTECTANTS 93

TABLE 29 MARKETED MUCOSAL PROTECTANT PRODUCTS 93

PROSTAGLANDINS 93

TABLE 30 MARKETED PROSTAGLANDIN PRODUCTS 94

STIMULANTS 94

TABLE 31 MARKETED STIMULANT PRODUCTS 94

MARKET SIZE AND GROWTH 95

TABLE 32 GLOBAL PRESCRIPTION OTHER GASTROINTESTINAL DRUG MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 95

FIGURE 17 GLOBAL PRESCRIPTION OTHER GASTROINTESTINAL DRUG MARKET BY REGION, 2007-2014 ($ MILLIONS) 95

COMPETITIVE STRUCTURE 96

TOTAL GLOBAL PRESCRIPTION GASTROINTESTINAL MARKET SIZE AND GROWTH 96

TABLE 33 GLOBAL PRESCRIPTION GASTROINTESTINAL DISORDER TREATMENT REVENUES BY CATEGORY, THROUGH 2014 ($ MILLIONS) 96

FIGURE 18 GLOBAL PRESCRIPTION GASTROINTESTINAL DISORDER TREATMENT REVENUES BY CATEGORY, 2007-2014 ($ MILLIONS) 97

TOTAL U.S. PRESCRIPTION GASTROINTESTINAL COMPETITIVE ANALYSIS 97

TABLE 34 MANUFACTURERS MARKET SHARE OF PRESCRIPTION GASTROINTESTINAL DISORDER TREATMENT REVENUES, (ESTIMATED 2009) 98

FIGURE 19 MANUFACTURERS MARKET SHARE OF PRESCRIPTION GASTROINTESTINAL DISORDER TREATMENT REVENUES, 2009 ESTIMATED (%) 99

Chapter-5: OTC PRODUCT SEGMENTS BY TYPE

ANTACIDS 100

SYSTEMIC ANTACIDS 101

Sodium Bicarbonate 101

NONSYSTEMIC ANTACIDS 101

Calcium Carbonate 101

Aluminum Products 102

Magnesium Products 102

C
'/>"/>